414 related articles for article (PubMed ID: 16954130)
41. Transesophageal echocardiography guided patent ductus arteriosus occlusion in adults with severe pulmonary hypertension through a parasternal approach.
Dai XF; Chen LW; Chen DZ; Chen Q; Zhen GZ; Zhang GC
Int J Clin Exp Pathol; 2015; 8(10):12300-6. PubMed ID: 26722416
[TBL] [Abstract][Full Text] [Related]
42. Percutaneous transcatheter closure of congenital coronary artery fistulae with patent ductus arteriosus occluder in children: focus on patient selection and intermediate-term follow-up results.
Wang C; Zhou K; Li Y; Qiao L; Wang Y; Shi X; Wang X; Zhao L; Xie L; Hua Y
J Invasive Cardiol; 2014 Jul; 26(7):339-46. PubMed ID: 24993992
[TBL] [Abstract][Full Text] [Related]
43. [Heart rate variability, adrenomedullin and B-type natriuretic peptide before and after transcatheter closure in children with patent ductus arteriosus].
Wu RZ; Rong X; Ren Y; He XX; Xiang RL
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Apr; 38(4):334-6. PubMed ID: 20654079
[TBL] [Abstract][Full Text] [Related]
44. Multicenter nit-occlud® PDA-R patent. Ductus arteriosus occlusion device trial: initial and six-month results.
Granja MA; Trentacoste L; Rivarola M; Barbosa JD; Lucini V; Peirone A; Spillman A
Catheter Cardiovasc Interv; 2015 Aug; 86(2):258-63. PubMed ID: 23460494
[TBL] [Abstract][Full Text] [Related]
45. Comparison of long-term clinical outcome between transcatheter Amplatzer occlusion and surgical closure of isolated patent ductus arteriosus.
Chen ZY; Wu LM; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
Chin Med J (Engl); 2009 May; 122(10):1123-7. PubMed ID: 19493456
[TBL] [Abstract][Full Text] [Related]
46. New minimally invasive technique of perpulmonary device closure of patent ductus arteriosus through a parasternal approach.
Hongxin L; Wenbin G; Zhu M; Liang F; Zhang W; Mujahid H; Zou C
Ann Thorac Surg; 2012 Mar; 93(3):862-8. PubMed ID: 22300626
[TBL] [Abstract][Full Text] [Related]
47. Transcatheter closure of patent ductus arteriosus: past, present and future.
Baruteau AE; Hascoët S; Baruteau J; Boudjemline Y; Lambert V; Angel CY; Belli E; Petit J; Pass R
Arch Cardiovasc Dis; 2014 Feb; 107(2):122-32. PubMed ID: 24560920
[TBL] [Abstract][Full Text] [Related]
48. [Closure of patent ductus arteriosus with duct occluder device in adult patients: evaluation of the approaches to facilitate the procedure].
Paç FA; Polat TB; Oflaz MB; Ballı S
Anadolu Kardiyol Derg; 2011 Feb; 11(1):64-70. PubMed ID: 21131255
[TBL] [Abstract][Full Text] [Related]
49. Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils.
Celiker A; Aypar E; Karagöz T; Dilber E; Ceviz N
Catheter Cardiovasc Interv; 2005 Aug; 65(4):569-76. PubMed ID: 15973674
[TBL] [Abstract][Full Text] [Related]
50. [Effects of transcatheter closure of extracardiac Fontan fenestration by Amplatzer duct or septal occluder in three patients].
Li SG; Jiang SL; Xu ZY; Huang LJ; Zhao SH; Jin JL; Yu JH; Xu JP
Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):489-92. PubMed ID: 19100057
[TBL] [Abstract][Full Text] [Related]
51. Concurrent transcatheter therapy of valvar aortic stenosis and patent ductus arteriosus.
Samraj R; Rao PS
J Invasive Cardiol; 2011 Apr; 23(4):E72-5. PubMed ID: 21474856
[TBL] [Abstract][Full Text] [Related]
52. The patent ductus arteriosus in term infants, children, and adults.
Schneider DJ
Semin Perinatol; 2012 Apr; 36(2):146-53. PubMed ID: 22414886
[TBL] [Abstract][Full Text] [Related]
53. Long-term follow-up results of lung perfusion studies after transcatheter closure of patent ductus arteriosus.
Demir F; Celebi A; Saritas T; Erdem A; Demir H; Firat MF; Polat TB
Congenit Heart Dis; 2013; 8(2):159-66. PubMed ID: 22897893
[TBL] [Abstract][Full Text] [Related]
54. Transcatheter closure of the patent ductus arteriosus: an intention to treat analysis.
Sheridan BJ; Ward CJ; Anderson BW; Justo RN
Heart Lung Circ; 2013 Jun; 22(6):428-32. PubMed ID: 23453524
[TBL] [Abstract][Full Text] [Related]
55. Transcatheter device closure of patent ductus arteriosus without arterial access--single institution experience.
Garg G; Srivastava A; Tyagi H; Reddy SP; Radha AS
Indian Heart J; 2013; 65(5):546-51. PubMed ID: 24206878
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary perfusion scans following transcatheter patent ductus arteriosus closure using the Amplatzer devices.
Kharouf R; Heitschmidt M; Hijazi ZM
Catheter Cardiovasc Interv; 2011 Apr; 77(5):664-70. PubMed ID: 21433271
[TBL] [Abstract][Full Text] [Related]
57. Stent angioplasty to relieve left pulmonary artery obstruction caused by patent ductus arteriosus device occlusion: bipartisan teamwork by two interventional devices.
Dean PN; Slack MC
Catheter Cardiovasc Interv; 2013 Sep; 82(3):480-4. PubMed ID: 23359589
[TBL] [Abstract][Full Text] [Related]
58. Patent ductus arteriosus associated with pulmonary hypertension and desaturation.
Khositseth A; Wanitkun S
Cardiol J; 2012; 19(5):543-6. PubMed ID: 23042324
[TBL] [Abstract][Full Text] [Related]
59. Outcomes of Percutaneous Closure of Patent Ductus Arteriosus Accompanied With Unilateral Absence of Pulmonary Artery.
Yang Y; Zheng H; Xu Z; Zhang G; Jin J; Hu H; Tian T; Zhou X
Am J Med Sci; 2017 Apr; 353(4):389-393. PubMed ID: 28317628
[TBL] [Abstract][Full Text] [Related]
60. Safety and Outcomes of Transcatheter Closure of Patent Ductus Arteriosus in Children With Pulmonary Artery Hypertension.
Salavitabar A; Krishnan US; Turner ME; Vincent JA; Torres AJ; Crystal MA
Tex Heart Inst J; 2020 Aug; 47(4):250-257. PubMed ID: 33472220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
